Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Editor'S comment.

Vaidya R, Shah R.

J Midlife Health. 2010 Jul;1(2):62. No abstract available.

2.

Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.

Golder S, Loke YK, Bland M.

PLoS Med. 2011 May;8(5):e1001026. doi: 10.1371/journal.pmed.1001026. Epub 2011 May 3. Review.

3.

Non interventional drug studies in oncology: Why we need them?

Mishra D, Vora J.

Perspect Clin Res. 2010 Oct;1(4):128-33. doi: 10.4103/2229-3485.71770.

4.

Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.

Krieger N, Löwy I, Aronowitz R, Bigby J, Dickersin K, Garner E, Gaudillière JP, Hinestrosa C, Hubbard R, Johnson PA, Missmer SA, Norsigian J, Pearson C, Rosenberg CE, Rosenberg L, Rosenkrantz BG, Seaman B, Sonnenschein C, Soto AM, Thornton J, Weisz G.

J Epidemiol Community Health. 2005 Sep;59(9):740-8. Review.

5.

Transparency in drug regulation: mirage or oasis?

Lexchin J, Mintzes B.

CMAJ. 2004 Nov 23;171(11):1363-5. No abstract available.

6.

Benefits and harms of drug treatments.

Vandenbroucke JP.

BMJ. 2004 Jul 3;329(7456):2-3. No abstract available.

7.

What doesn't work and how to show it.

Alderson P, Groves T.

BMJ. 2004 Feb 28;328(7438):473. No abstract available.

Supplemental Content

Support Center